# å·²ç¡®è®¤é˜ˆå€¼æ±‡æ€» (v2.0)

> æœ€åæ›´æ–°: 2025-01-24
>
> **æ›´æ–°è¯´æ˜**: é€šè¿‡æ–‡çŒ®æ£€ç´¢ï¼Œå°†13ä¸ªåŸpendingæŒ‡æ ‡æå‡ä¸ºconfirmedçŠ¶æ€

æœ¬æ–‡æ¡£æ±‡æ€»æ‰€æœ‰å·²ç¡®è®¤çš„ä¸´åºŠé˜ˆå€¼ï¼ŒåŒ…å«æ¥æºå’Œç½®ä¿¡åº¦æ ‡è®°ã€‚

---

## ç½®ä¿¡åº¦è¯´æ˜

| ç­‰çº§ | å«ä¹‰ | åº”ç”¨ |
|------|------|------|
| **é«˜ (High)** | å¤šä¸ªæƒå¨æ¥æºæ”¯æŒï¼Œä¸´åºŠå¹¿æ³›è®¤å¯ | å¯ç›´æ¥ç”¨äºè‡ªåŠ¨åŒ–å†³ç­– |
| **ä¸­ (Medium)** | æœ‰æ–‡çŒ®æ”¯æŒï¼Œä½†å¯èƒ½å­˜åœ¨å˜å¼‚ | å¯ç”¨äºå†³ç­–å‚è€ƒï¼Œå»ºè®®äººå·¥å¤æ ¸ |
| **ä½ (Low)** | ä»…å ä½æˆ–å°‘é‡æ¥æºï¼Œéœ€è¿›ä¸€æ­¥éªŒè¯ | ä»…ä¾›å‚è€ƒï¼Œä¸å»ºè®®è‡ªåŠ¨å†³ç­– |
| **å¾…å®š (Pending)** | æ— ç¡®è®¤é˜ˆå€¼ | ä»…ç›‘æµ‹è®°å½• |

---

## 1. å¿ƒåŠŸèƒ½æŒ‡æ ‡

### EF - å°„è¡€åˆ†æ•°
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | ISHLT Guidelines, Clinical consensus | |
| **æ¥å—** | > 50% | å¯æ¥å— |
| **æ‹’ç»** | < 40% | æ‹’ç»å™¨å®˜ |
| **ç°åŒº** | 45-50% | éœ€ç»¼åˆè¯„ä¼° |
| **Baseline** | 55% | |

### CI - å¿ƒè„æŒ‡æ•°
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | Hemodynamic guidelines, Critical care standards | |
| **ç›®æ ‡èŒƒå›´** | 2.2-2.8 L/min/mÂ² | |
| **çº¢çº¿** | < 2.0 L/min/mÂ² | éœ€å¹²é¢„ |
| **å‡çº§è§„åˆ™** | CI < 2.0 ä¸”å¤è‹æ— æ•ˆ â†’ æ­£æ€§è‚ŒåŠ›è¯ç‰© | |

---

## 2. è¡€å‹æŒ‡æ ‡

### MAP - å¹³å‡åŠ¨è„‰å‹
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | Hemodynamic guidelines | |
| **ç›®æ ‡èŒƒå›´** | 65-80 mmHg | |
| **çº¢çº¿** | < 60 mmHg | |

### AOP - ä¸»åŠ¨è„‰å‹ (OCS)
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | Prot_000 OCS Protocol | |
| **æ“ä½œèŒƒå›´** | 40-100 mmHg | OCSç³»ç»Ÿ |
| **è­¦å‘Š** | < 70 mmHg | |

---

## 3. æ°§ä»£è°¢æŒ‡æ ‡

### SvOâ‚‚ - æ··åˆé™è„‰è¡€æ°§é¥±å’Œåº¦
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | Critical care guidelines | |
| **ç›®æ ‡** | â‰¥ 65% | |
| **çº¢çº¿** | < 60% | |
| **å±æ€¥å€¼** | < 50% | è”åˆCIä¸‹é™éœ€å‡çº§æ”¯æŒ |
| **å‡çº§è§„åˆ™** | SvOâ‚‚ < 50% + CIä¸‹é™ â†’ æ­£æ€§è‚ŒåŠ›/è‚ºè¡€ç®¡æ‰©å¼  Â± MCS | |

### pOâ‚‚V - é™è„‰è¡€æ°§åˆ†å‹ âœ… å·²éªŒè¯
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | **å·²ä»ä½æå‡** |
| **æ¥æº** | [BMC Pulmonary Medicine 2022](https://link.springer.com/article/10.1186/s12890-022-02073-0), [Deranged Physiology](https://derangedphysiology.com/main/cicm-primary-exam/cardiovascular-system/Chapter-039/mixed-venous-oxygen-and-carbon-dioxide-content) | |
| **ç›®æ ‡èŒƒå›´** | 35-45 mmHg | å…¸å‹å€¼~40 mmHg |
| **è­¦å‘Š** | < 35 mmHg | ç»„ç»‡ç¼ºæ°§è­¦å‘Š |
| **çº¢çº¿** | < 32 mmHg | æ—©æœŸå¾ªç¯ä¸è¶³ |

### CvOâ‚‚ - é™è„‰è¡€æ°§å«é‡ âœ… æ–°å¢
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [NCBI StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK564395/), [OpenAnesthesia](https://www.openanesthesia.org/cv_physiology_mixed_venous_oxygen/) | |
| **ç›®æ ‡èŒƒå›´** | 14-16 mL/dL | å…¸å‹å€¼~15 mL/dL |
| **è­¦å‘Š** | < 12 mL/dL | æ°§æ‘„å–å¢åŠ  |
| **çº¢çº¿** | < 10 mL/dL | ä¸¥é‡ç»„ç»‡ç¼ºæ°§ |
| **å¤‡æ³¨** | CaOâ‚‚-CvOâ‚‚å·®å€¼æ­£å¸¸4-6 mL/dL | æ°§æå–ç‡25-35% |

---

## 4. ä»£è°¢æŒ‡æ ‡

### Lactate - ä¹³é…¸
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | OCS Protocol, Critical care guidelines, [TransMedics FDA](https://www.accessdata.fda.gov/cdrh_docs/pdf18/P180051S001D.pdf) | |
| **ç†æƒ³** | < 2 mmol/L | |
| **å¯æ¥å—** | < 5 mmol/L | OCSæ¥å—æ ‡å‡† |
| **ä¸åˆæ ¼** | > 5 mmol/L | |
| **è­¦æˆ’** | > 4 mmol/L | |

---

## 5. ç”µè§£è´¨æŒ‡æ ‡ âœ… æ–°å¢

### KâºA - åŠ¨è„‰é’¾ç¦»å­
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | [JACC 2003](https://www.jacc.org/doi/10.1016/j.jacc.2003.06.021), [ACC 2020](https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2020/06/02/14/26/Abnormalities-of-Potassium-in-Heart-Failure), [NCBI StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK539791/) | |
| **ICUæœ€ä½³** | 4.0-5.0 mmol/L | å¿ƒè¡€ç®¡æ‚£è€…æ¨è |
| **æ­£å¸¸èŒƒå›´** | 3.5-5.0 mmol/L | |
| **ä½é’¾è­¦æˆ’** | < 3.5 mmol/L | å¿ƒå¾‹å¤±å¸¸é£é™© |
| **é«˜é’¾è­¦æˆ’** | > 5.5 mmol/L | |
| **ä½é’¾çº¢çº¿** | < 3.0 mmol/L | ä¸¥é‡ä½é’¾ |
| **é«˜é’¾çº¢çº¿** | > 6.0 mmol/L | ä¸¥é‡é«˜é’¾ |
| **å±æ€¥å€¼** | > 6.5 mmol/L | å¿ƒè„éª¤åœé£é™© |

### NaâºA - åŠ¨è„‰é’ ç¦»å­
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | [Critical Care 2012](https://ccforum.biomedcentral.com/articles/10.1186/cc11805), [JAHA](https://www.ahajournals.org/doi/10.1161/JAHA.119.014140) | |
| **æ­£å¸¸èŒƒå›´** | 135-145 mmol/L | |
| **ä½é’ è­¦æˆ’** | < 130 mmol/L | |
| **é«˜é’ è­¦æˆ’** | > 150 mmol/L | |
| **ä½é’ çº¢çº¿** | < 125 mmol/L | ç¥ç»ç—‡çŠ¶é£é™© |
| **é«˜é’ çº¢çº¿** | > 155 mmol/L | |
| **å±æ€¥å€¼ä½** | < 120 mmol/L | |
| **å±æ€¥å€¼é«˜** | > 160 mmol/L | |

### GluA - åŠ¨è„‰è¡€ç³–
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | [ADA 2025](https://diabetesjournals.org/care/article/49/Supplement_1/S339/163925/16-Diabetes-Care-in-the-Hospital-Standards-of-Care), [SCCM Guidelines](https://www.sccm.org/clinical-resources/guidelines/guidelines/guidelines-on-glycemic-control-for-critically-ill), [NEJM NICE-SUGAR](https://www.nejm.org/doi/full/10.1056/NEJMoa0810625) | |
| **ICUç›®æ ‡** | 7.8-10.0 mmol/L | 140-180 mg/dL |
| **é«˜è¡€ç³–** | > 10.0 mmol/L | è€ƒè™‘èƒ°å²›ç´  |
| **ä½è¡€ç³–1çº§** | < 3.9 mmol/L | <70 mg/dL |
| **ä½è¡€ç³–2çº§** | < 3.0 mmol/L | <54 mg/dL |
| **ä¸¥é‡ä½è¡€ç³–** | < 2.2 mmol/L | â‰¤40 mg/dL |
| **å¤‡æ³¨** | ä¸¥æ ¼æ§åˆ¶(<7.8)åè€Œå¢åŠ æ­»äº¡ç‡(NICE-SUGAR) | |

---

## 6. å¿ƒç‡æŒ‡æ ‡

### HR - å¿ƒç‡
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | Clinical standards | |
| **æ­£å¸¸èŒƒå›´** | 60-100 bpm | |
| **è­¦æˆ’èŒƒå›´** | 110-120 bpm | |

---

## 7. è‚ºè¡€ç®¡æŒ‡æ ‡

### PVR - è‚ºè¡€ç®¡é˜»åŠ›
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | ISHLT Guidelines | |
| **ç›®æ ‡** | < 2.5 Wood Units | |
| **è­¦æˆ’** | > 2.5 Wood Units | |
| **çº¢çº¿** | > 3.0 Wood Units | |

---

## 8. å† è„‰çŒæ³¨æŒ‡æ ‡

### CF - å† è„‰æµé‡
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | Prot_000 OCS Protocol | |
| **ç›®æ ‡èŒƒå›´** | 400-900 mL/min | OCSç³»ç»Ÿ |

---

## 9. æœ¯åç›‘æµ‹æŒ‡æ ‡

### èƒ¸è…”å¼•æµ
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¢ é«˜ | |
| **æ¥æº** | Post-surgical protocols | |
| **è­¦æŠ¥æ¡ä»¶** | > 200 mL/h æŒç»­ 6-8h | éœ€è¯„ä¼°å‡ºè¡€ |

---

## 10. å¿ƒè‚ŒåŠ›å­¦æŒ‡æ ‡ âœ… æ–°å¢

### Max dP/dt - æœ€å¤§å‹åŠ›å˜åŒ–ç‡
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [AHA Circulation](https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.44.1.47), [Critical Care 2018](https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2260-1), [BMC Cardiovascular](https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/1471-2261-12-13) | |
| **æ­£å¸¸èŒƒå›´** | 1200-1800 mmHg/s | å·¦å¿ƒå®¤ |
| **è­¦å‘Š** | < 1200 mmHg/s | æ”¶ç¼©åŠ›ä¸‹é™ |
| **çº¢çº¿** | < 1000 mmHg/s | ä¸¥é‡åŠŸèƒ½éšœç¢ |
| **å¤‡æ³¨** | RVæ­£å¸¸~250 mmHg/sï¼›å—å‰è´Ÿè·å½±å“ | |

### Tau (Ï„) - èˆ’å¼ æ—¶é—´å¸¸æ•°
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [Nagueh et al 2009](https://pubmed.ncbi.nlm.nih.gov/8994430/), [Grant et al 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC2570579/) | |
| **æ­£å¸¸èŒƒå›´** | 30-45 ms | |
| **è­¦å‘Š** | > 48 ms | èˆ’å¼ åŠŸèƒ½éšœç¢ä¸´åºŠæˆªæ–­å€¼ |
| **çº¢çº¿** | > 60 ms | ä¸¥é‡èˆ’å¼ åŠŸèƒ½éšœç¢ |

### Emax (Ees) - ç«¯æ”¶ç¼©å¼¹æ€§
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [Critical Care 2016](https://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1439-6), [JACC](https://www.jacc.org/doi/10.1016/S0735-1097(01)01651-5) | |
| **æ­£å¸¸èŒƒå›´** | 1.5-3.5 mmHg/mL | éç´¢å¼•å€¼ |
| **å…¸å‹å€¼** | 2.3 Â± 1.0 mmHg/mL | |
| **è­¦å‘Š** | < 1.5 mmHg/mL | æ”¶ç¼©åŠ›ä¸‹é™ |
| **çº¢çº¿** | < 1.0 mmHg/mL | ä¸¥é‡åŠŸèƒ½éšœç¢ |
| **å¤‡æ³¨** | ç´¢å¼•å€¼7.1Â±2.4 mmHgÂ·mLâ»Â¹Â·mâ»Â²ï¼›è´Ÿè·ç‹¬ç«‹ | |

### End-Systolic Pressure - ç«¯æ”¶ç¼©å‹
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [CV Physiology](https://cvphysiology.com/cardiac-function/cf024), Kelly et al 1992 | |
| **æ­£å¸¸èŒƒå›´** | 90-120 mmHg | â‰ˆ0.9Ã—SBP |
| **è­¦å‘Šä½** | < 80 mmHg | ä½è¡€å‹/æ”¶ç¼©ä¸‹é™ |
| **è­¦å‘Šé«˜** | > 140 mmHg | åè´Ÿè·å¢åŠ  |

### LVET - å·¦å®¤å°„è¡€æ—¶é—´
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | [AHA Circulation](https://www.ahajournals.org/doi/10.1161/01.CIR.37.2.149), [Wiley](https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.2125) | |
| **æ­£å¸¸èŒƒå›´** | 280-360 ms | FTcæ ¡æ­£å€¼330-360ms |
| **è­¦å‘ŠçŸ­** | < 280 ms | å¯èƒ½å¿ƒåŠŸèƒ½ä¸‹é™ |
| **å¤‡æ³¨** | å¿ƒè¡°æ—¶å°„è¡€æ—¶é—´ç¼©çŸ­ | |

### Developed Pressure - äº§ç”Ÿå‹åŠ›
| é¡¹ç›® | å€¼ | è¯´æ˜ |
|------|-----|------|
| **ç½®ä¿¡åº¦** | ğŸŸ¡ ä¸­ | |
| **æ¥æº** | Catheterization studies, Langendorff references | |
| **æ­£å¸¸èŒƒå›´** | 80-120 mmHg | Peak Systolic - End-Diastolic |
| **è­¦å‘Š** | < 70 mmHg | æ”¶ç¼©åŠŸèƒ½ä¸‹é™ |
| **çº¢çº¿** | < 50 mmHg | ä¸¥é‡åŠŸèƒ½éšœç¢ |

---

## å‡çº§æ”¯æŒç­–ç•¥æ±‡æ€»

| è§¦å‘æ¡ä»¶ | ç½®ä¿¡åº¦ | ç­–ç•¥ |
|----------|--------|------|
| SvOâ‚‚ < 50% æˆ– CIä¸‹é™ä¸”å¤è‹æ— æ•ˆ | ğŸŸ¡ ä¸­ | æ­£æ€§è‚ŒåŠ›è¯ç‰©/è‚ºè¡€ç®¡æ‰©å¼  Â± MCS |
| å¤šæŒ‡æ ‡åŒæ—¶è§¦å‘çº¢çº¿ | ğŸŸ¡ ä¸­ | å¯åŠ¨è¡€æµåŠ¨åŠ›å­¦ä¸ç¨³å®šå‡çº§æ–¹æ¡ˆ |
| PVR > 3.0 WU | ğŸŸ¢ é«˜ | è‚ºè¡€ç®¡æ‰©å¼ å‰‚æ²»ç–— |
| Lactate > 5 | ğŸŸ¢ é«˜ | è¯„ä¼°å™¨å®˜è´¨é‡ï¼Œè€ƒè™‘æ‹’ç» |
| Kâº > 6.5 mmol/L | ğŸŸ¢ é«˜ | ç´§æ€¥å¤„ç†é«˜é’¾è¡€ç—‡ |
| Kâº < 3.0 mmol/L | ğŸŸ¢ é«˜ | ç´§æ€¥è¡¥é’¾ |
| è¡€ç³– < 2.2 mmol/L | ğŸŸ¢ é«˜ | ç´§æ€¥çº æ­£ä½è¡€ç³– |

---

## æŒ‡æ ‡ç»Ÿè®¡

| ç±»åˆ« | é«˜ç½®ä¿¡åº¦ | ä¸­ç½®ä¿¡åº¦ | æ€»è®¡ |
|------|----------|----------|------|
| å¿ƒåŠŸèƒ½ | 1 | 1 | 2 |
| è¡€å‹ | 1 | 1 | 2 |
| æ°§ä»£è°¢ | 0 | 3 | 3 |
| ä»£è°¢ | 1 | 0 | 1 |
| ç”µè§£è´¨ | 3 | 0 | 3 |
| å¿ƒç‡ | 1 | 0 | 1 |
| è‚ºè¡€ç®¡ | 1 | 0 | 1 |
| å† è„‰çŒæ³¨ | 1 | 0 | 1 |
| æœ¯åç›‘æµ‹ | 1 | 0 | 1 |
| å¿ƒè‚ŒåŠ›å­¦ | 0 | 6 | 6 |
| **æ€»è®¡** | **10** | **11** | **21** |
